APA (7th ed.) Citation

Zhang X, He Z, Xiang L, Li L, Zhang H, Lin F, & Cao H. (2019). Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhang X, He Z, Xiang L, Li L, Zhang H, Lin F, and Cao H. Codelivery of GRP78 SiRNA and Docetaxel via RGD-PEG-DSPE/DOPA/CaP Nanoparticles for the Treatment of Castration-resistant Prostate Cancer. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Zhang X, et al. Codelivery of GRP78 SiRNA and Docetaxel via RGD-PEG-DSPE/DOPA/CaP Nanoparticles for the Treatment of Castration-resistant Prostate Cancer. Dove Medical Press, 2019.